Clinical Trial Update: Spectral Analysis Probe to Identify Glioblastoma Cells

View source ↗

Summary

A University of Oklahoma-sponsored clinical trial evaluating a spectral analysis probe to identify glioblastoma cells has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: University of Oklahoma | Conditions: Glioblastoma | Status: TERMINATED